This site is intended for US healthcare professionals.

FOTIVDA: 3 weeks on treatment and 1 week off¹

FOTIVDA: 3 weeks on treatment and 1 week off¹

One 1.34-mg capsule
Once-daily with water
With or without food
21 days on / 7 days off (28-day cycle)
0.89-mg strength available for patients with moderate hepatic impairment or if dose reduction is needed

FOTIVDA® (tivozanib) 1.34 mg capsule bottle and bottle resting on feather.

Capsule shown not actual size.

Download the Dosing Guide for FOTIVDA.

View dose modifications.

See results from the pivotal trial.

See real-world experience with FOTIVDA.

Watch the Video

Reference: 1. FOTIVDA (tivozanib) [package insert]. Boston, MA: AVEO Pharmaceuticals, Inc, August 2024.